State-of-the-art science driving disruptive small molecule drug, biologic drug and drug delivery, and companion diagnostic programs.
Proprietary Droplet Digital PCR (ddPCR) and Next-Generation Sequencing (NGS) based liquid biopsy companion diagnostic tests employing engineered enzymes that reduce GC-bias as well as customized data analysis software.